Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Probe(s) Labeling This Target
ABPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
TH211 Probe Info |
![]() |
Y218(7.33); Y191(6.17) | LDD0260 | [1] | |
|
IA-alkyne Probe Info |
![]() |
N.A. | LDD0036 | [2] | |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Other
| Protein name | Family | Uniprot ID | |||
|---|---|---|---|---|---|
| Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1) | PI3K p85 subunit family | P27986 | |||
The Drug(s) Related To This Target
Approved
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Belatacept | . | D0N4HB | |||
Phase 3
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Ab-103 | Small molecular drug | D04HQJ | |||
Phase 2
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Regn5678 | Antibody | D8UZM7 | |||
| Au101 | . | D0T9JW | |||
| Lulizumab Pegol | . | D0GB5X | |||
Phase 1
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Sar442257 | Antibody | DBP9Q5 | |||
| Cd19-car And Cd28-car T Cells | CAR T Cell Therapy (Dual specific) | D0QE4F | |||
| Cd28 And Cd137 Car-t Cells | CAR T Cell Therapy (Dual specific) | D0JY0M | |||
Investigative
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Anti-cd28 | Antibody | D0V9LF | |||
| Fr-104 | Antibody | D0A2MA | |||
Discontinued
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Tgn-1412 | Antibody | D00PNU | |||
References


